Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement
You can also search for this author in PubMed Google Scholar
A drug widely used to treat COVID-19 might be spurring the evolution of new SARS-CoV-2 variants.
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 614, 399 (2023)
doi: https://doi.org/10.1038/d41586-023-00347-z
Sanderson, T., Hisner, R., Donovan-Banfield, I., Peacock, T. & Ruis, C. Preprint at medRxiv https://doi.org/10.1101/2023.01.26.23284998 (2023).
Rosenke, K. et al. Nature Commun. 12, 2295 (2021).
Article Google Scholar
Butler, C. C. et al. Lancet 401, 281–293 (2023).
Article Google Scholar
Download references
Reprints and Permissions
How antiviral pill molnupiravir shot ahead in the COVID drug hunt
Merck’s COVID pill loses its lustre: what that means for the pandemic
Hundreds of COVID trials could provide a deluge of new drugs
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes
Article
COVID vaccines linked to unexpected vaginal bleeding
News
Distinguishing features of Long COVID identified through immune profiling
Article
Is depression lifting? AI that interprets brain waves has answers
News
Cingulate dynamics track depression recovery with deep brain stimulation
Article
A multi-stem cell basis for craniosynostosis and calvarial mineralization
Article
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes
Article
COVID vaccines linked to unexpected vaginal bleeding
News
Distinguishing features of Long COVID identified through immune profiling
Article
Position Description Brain Immunology and Glia (BIG) Center at the Washington University School of Medicine invites applications for a tenure-track…
Saint Louis, Missouri
Washington University School of Medicine – St. Louis
Postdoctoral Research Associate Division of Rheumatology and Immunology Project Information Four funded Postdoctoral Associate position is availabl…
Chicago, Illinois
UIC
Founded by prominent scientists and scholars, Westlake is committed to building a truly international, world-leading, research-focused university.
Hangzhou, Zhejiang, China
Westlake University
Founded in 2018, Westlake University is a new type of non-profit research-oriented university in Hangzhou, China, supported by public a…
Hangzhou
Westlake University
The University of Freiburg offers several Ph.D. positions (m/f/d) in Dilution Energy Systems.
Freiburg im Breisgau, Baden-Württemberg (DE)
University of Freiburg, Germany
How antiviral pill molnupiravir shot ahead in the COVID drug hunt
Merck’s COVID pill loses its lustre: what that means for the pandemic
Hundreds of COVID trials could provide a deluge of new drugs
An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.
Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.
© 2023 Springer Nature Limited